Internal Medicine Displays Research from Young Investigators
The Department of Internal Medicine held the 2016 Trainees Research Grand Rounds on Friday, June 10, 2016. This year, there were 43 posters presented and 39 mentors. Gregory Rouan, MD, chair, Department of Internal Medicine, Manoocher Soleimani, MD, associate chair for Research, and Carl Fichtenbaum, MD, associate chair for translational research, offered thanks to the trainees and their mentors for putting together the research presentations along with the 49 faculty who served as judges of the event.
The winning presentations in the basic science and clinical studies are listed below:
Basic Science Awards:
First place ($500)
Jamie Tweedle, MS
Mentor: George Deepe, MD, Infectious Diseases
"TNFα antagonism promotes gut to lung migration of CD11b+CD103+ dendritic cells that amplify regulatory T cells in lung infection
Second place ($250)
Megan Vogel, BS
Mentor: Stephen D. Zucker, MD, Digestive Diseases
"Bilirubin prevents atherosclerotic lesion formation in LDL receptor-deficient mice by inhibiting endothelial VCAM-1 and ICAM-1 signaling
Honorable Mention ($150)
Cindy Hochstetler, BS
Mentor: Yi Zheng, PhD, Experimental Biology and Cancer Biology
"Impact of an Abnormal Bone Marrow Endothelial Niche on Hematopoiesis
Clinical Research Awards:
First place ($375) - Tie
Mariam Anis, MD
Mentor: Jean Elwing, MD, Pulmonary, Critical Care and Sleep Medicine
"Successful Treatment of Idiopathic Pulmonary Vasculopathy with Targeted Pulmonary Vasodilator Therapy
First place ($375) - Tie
Su Ah Bae
Mentor: Abid Yaqub, MD, Endocrinology, Diabetes and Metabolism
"Autosomal Dominant Hypophosphatemic Rickets (ADHR) presenting in an adult patient without growth restriction or skeletal deformities
Honorable Mention ($150)
Adam Rose, MD and Muhammad Zafar, MD
Mentor: Mark H. Eckman, MD, General Internal Medicine
"Impact of Lung Volume Reduction Surgery (LVRS) versus Endobronchial Valves (EBV) in Patients with Heterogeneous Emphysema: A Decision Analysis
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.